APA (7th ed.) Citation

A, S., C, C., R, J., J, H., MA, T., LC, K., . . . Z, A. (2018). Maternal sildenafil for severe fetal growth restriction (STRIDER): A multicentre, randomised, placebo-controlled, double-blind trial. The Lancet. Child & adolescent health, 2(2), 93. https://doi.org/10.1016/S2352-4642(17)30173-6

Chicago Style (17th ed.) Citation

A, Sharp, et al. "Maternal Sildenafil for Severe Fetal Growth Restriction (STRIDER): A Multicentre, Randomised, Placebo-controlled, Double-blind Trial." The Lancet. Child & Adolescent Health 2, no. 2 (2018): 93. https://doi.org/10.1016/S2352-4642(17)30173-6.

MLA (9th ed.) Citation

A, Sharp, et al. "Maternal Sildenafil for Severe Fetal Growth Restriction (STRIDER): A Multicentre, Randomised, Placebo-controlled, Double-blind Trial." The Lancet. Child & Adolescent Health, vol. 2, no. 2, 2018, p. 93, https://doi.org/10.1016/S2352-4642(17)30173-6.